Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.280
-0.030 (-0.91%)
At close: Feb 18, 2026, 4:00 PM EST
3.340
+0.060 (1.83%)
After-hours: Feb 18, 2026, 5:20 PM EST
Exagen Market Cap
Exagen has a market cap or net worth of $74.33 million as of February 18, 2026. Its market cap has increased by 5.37% in one year.
Market Cap
74.33M
Enterprise Value
67.53M
1-Year Change
5.37%
Ranking
Category
Stock Price
$3.28
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $74.33M, an increase of 17.79%. That is a compound annual growth rate of 2.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 75.01M | -45.56% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Myriad Genetics | 418.53M |
| Prenetics Global | 369.72M |
| Burning Rock Biotech | 313.68M |
| Insight Molecular Diagnostics | 180.99M |
| MDxHealth | 174.64M |
| FONAR | 121.54M |
| Biodesix | 91.09M |
| Precipio | 40.98M |